Differences between revisions 10 and 12 (spanning 2 versions)
Revision 10 as of 2008-07-19 04:16:48
Size: 1782
Editor: GaryBader
Comment:
Revision 12 as of 2008-07-19 15:53:00
Size: 2035
Editor: GaryBader
Comment:
Deletions are marked like this. Additions are marked like this.
Line 16: Line 16:
 * Allan Kuchinsky (Agilent Technologies, San Francisco Bay area)
Line 23: Line 24:
 * David States (University of Michigan)
Line 26: Line 28:
 * Update on Cytoscape (Mike Smoot)
* New secretary/treasurer (Trey)
 * Cytoscape book - what's the goal? (Gary)
 * More face to face core developer meetings - 3/year on west coast?
* More open core development mailing list?
 * Cytoscape Status Update (Mike Smoot, Cytoscape Chief Architect)
 * Matters arising from the Cytoscape Retreat
 
* New secretary/treasurer (Trey)
  * Cytoscape book - what's the goal? (Gary)
  * More face to face core developer meetings - 3/year on west coast? (Gary)
 
* More open core development mailing list? (Gary)
Line 32: Line 35:
 * Scientific directions  * Scientific directions. Goal: create a scientific vision for Cytoscape

Cytoscape Board Meeting

Description

This is a private meeting of the Cytoscape board of directors and scientific advisory board members to discuss Cytoscape strategy, funding and scientific directions, as part of the [http://www.cytoscape.org/cgi-bin/moin.cgi/CytoscapeRetreat2008 Cytoscape retreat].

Attendees

  • Trey Ideker (University of California, San Diego)
  • Gary Bader (University of Toronto)
  • Annette Adler (Agilent Technologies, San Francisco Bay area)
  • Allan Kuchinsky (Agilent Technologies, San Francisco Bay area)
  • Alex Pico (in lieu of Bruce Conklin) (Gladstone Institute of Cardiovascular Disease, UCSF, San Francisco)
  • Benno Schwikowski (Institut Pasteur, Paris)
  • Chris Sander (Memorial Sloan-Kettering Cancer Center, New York)
  • Charlie Boone (University of Toronto)
  • Mark Gerstein (Yale University)
  • Shoshana Wodak (Hospital for Sick Children, Toronto)
  • Yeyejide Adeleye (Unilever, UK)
  • David States (University of Michigan)

Agenda

  • Cytoscape Status Update (Mike Smoot, Cytoscape Chief Architect)
  • Matters arising from the Cytoscape Retreat
    • New secretary/treasurer (Trey)
    • Cytoscape book - what's the goal? (Gary)
    • More face to face core developer meetings - 3/year on west coast? (Gary)
    • More open core development mailing list? (Gary)
  • Funding (Trey)
  • Scientific directions. Goal: create a scientific vision for Cytoscape

Notes

CytoscapeRetreat2008/BoardMeeting (last edited 2009-02-12 01:03:27 by localhost)

Funding for Cytoscape is provided by a federal grant from the U.S. National Institute of General Medical Sciences (NIGMS) of the Na tional Institutes of Health (NIH) under award number GM070743-01. Corporate funding is provided through a contract from Unilever PLC.

MoinMoin Appliance - Powered by TurnKey Linux